Luoyang Molybdenum Industry (03993.HK) plans to invest 500 million yuan to participate in a private equity investment fund, focusing on three sunrise industries: technology, medical health, and consumer goods and retail.

Intelligence Finance and Economics APP news, Luoyang Molybdenum Industry (03993.HK) announced that the company's wholly-owned subsidiary Tibet Shimoer (as a limited partner), Boyu Tianshu (as a general partner), and Boyu New Wisdom and Innovation (Ningbo) Equity Investment Partnership Enterprise (limited partner) (the fund) entered into a partnership agreement with other limited partners of the fund. Accordingly, the contracting parties agreed to invest in the fund, with Tibet Shimoer agreeing to invest RMB 500 million in the fund. The target size of the fund is RMB 8-10 billion, focusing mainly on the three sunrise industries of technology, medical health, consumer goods, and retail.